Since its debut, the quick CSF method has been further tested and applied in several studies. Hou et al. (
2010) validated the quick CSF method in patients with amblyopia and demonstrated that the procedure can achieve a 0.24 log unit standard deviation with 50 trials. Dorr, Lesmes, Lu, & Bex (
2013) implemented the procedure on a tablet device and demonstrated that CSFs obtained on a tablet device are comparable to those obtained with specialized laboratory equipment. The method has been applied to investigate the dynamic effects of visual adaptation (Gepshtein, Lesmes, & Albright,
2013) and emotional arousal (Lee, Baek, Lu, & Mather,
2014) on the contrast sensitivity function. It has also been validated in applications studying peripheral vision (Rosén, Lundström, Venkataraman, Winter, & Unsbo,
2014) and second-order perception (Reynaud, Tang, Zhou, & Hess,
2014), with a 0.07 log unit standard deviation with approximate 10 min of testing time reported by Rosen et al. (
2014). With the procedure implemented on a tablet device, Kalia et al. (
2014) demonstrated surprising visual development in a unique sample of patients who experienced extended early-onset blindness before removal of bilateral congenital cataracts. The quick CSF method has also been validated in populations with macular degeneration (Lesmes, Wallis, Jackson, & Bex,
2013; Lesmes, Wallis, Lu, Jackson, & Bex,
2012; Rosen et al.,
2015) and glaucoma (Ramulu, Dave, & Friedman,
2015). Several quick CSF studies on clinical populations, including age-related macular degeneration (AMD), amblyopia, and glaucoma, showed that a similar or slightly (<25%) higher number of trials was required to achieve the same precision in clinical populations as in normal subjects, and the test precision did not depend on the patients' overall level of visual deficits (Hou et al.,
2010; Lesmes et al.,
2013; Lesmes et al.,
2012; Rosen et al.,
2015).